November 2, 2022
A collaborative research team at the University of Cincinnati has received a $3.5 million National Institutes of Health grant to examine how current HIV medications are affected by alcohol use alone or in combination with fentanyl.
August 10, 2022
University of Cincinnati researchers Jason Gardner and Matthew Robson are studying whether targeting an inflammation pathway that affects burns and traumatic brain injuries can be an effective treatment for both conditions.
August 14, 2023
A federally funded study, led by University of Cincinnati researcher Nalinikanth Kotagiri, looks to develop a new imaging method that can identify certain types of lung infections — in real time — in order to speed up treatment for critically ill patients.
August 17, 2023
Cincinnati news outlets covered the opening of the University of Cincinnati's Bioscience Center, which will collaborate with doctors to create groundbreaking medical technology.
April 11, 2023
Patient care and individual well-being are increasingly guided by personalized information integrated from genetic factors, environmental exposure and nutritional status — these and many more topics were covered during the University of Cincinnati's James L. Winkle College of Pharmacy's inaugural Pharmaceutical/Cosmetic Science, Pharmacotherapy and Personalized Healthcare conference in early April.
March 22, 2023
Local 12 highlighted the University of Cincinnati's Bingfang Yan, who recently received a a $2.5 million National Institutes of Health grant to study how COVID-19 therapeutics can work together to create more effective and safe treatments for patients.
March 16, 2023
The University of Cincinnati's Bingfang Yan's research team has received a $2.5 million National Institutes of Health grant to answer the question of how FDA-approved COVID-19 therapeutics can work together to create more effective and safe treatments for patients.
March 28, 2023
Researchers led by the University of Cincinnati's Nalinikanth Kotagiri, PhD, have published new research showing proof of concept for using engineered bacteria as an adapter to deliver targeted radionuclide treatment to tumors.
April 14, 2023
Physics World highlighted research led by the University of Cincinnati's Nalinikanth Kotagiri that shows a proof of concept for using engineered bacteria as an adapter to deliver targeted radionuclide treatment to tumors.
October 19, 2023
The University of Cincinnati’s Timothy Phoenix is one of the investigators on a research team that is part of a new NCI Pediatric Immunotherapy Network and studying how to improve immunotherapy treatments for pediatric brain tumors.